Investor Relations
And information
HomeInvestor Relations› Wright Medical Group, Inc. Launches DYNASTY(R) BIOFOAM(TM) Acetabular Cup System
News Releases
View printer-friendly version << Back
Wright Medical Group, Inc. Launches DYNASTY(R) BIOFOAM(TM) Acetabular Cup System

Bone-Like Titanium Brings “Fixation With Bite™” To Wright’s Innovative Hip Cup Line

ARLINGTON, Tenn.--(BUSINESS WIRE)--Oct. 15, 2009-- Wright Medical Group, Inc. (NASDAQ: WMGI), a global orthopaedic medical device company, today announced the launch of the DYNASTY® BIOFOAM™ Acetabular Cup System. This latest addition to the DYNASTY® system features proprietary bone-like titanium with a roughened texture that “bites” into bone for enhanced immediate fixation when compared to traditional porous beads. The BIOFOAM™ material also features a trabecular structure intended to mimic bone and contribute to bone in-growth and biological fixation.

Commenting on his surgical experiences with the DYNASTY® BIOFOAM™ system, Lowry C. Barnes, M.D. of St. Vincent Orthopedic Center in Little Rock, Arkansas stated, “The application of the BIOFOAM™ material, a novel bone in-growth surface, to the already successful DYNASTY® socket provides the surgeon confidence in challenging situations and allows the patient the many advantages of A-CLASS® metal bearings and larger diameter femoral head technology.”

Michael Carroll, Senior Director of Wright’s Implant Technology Group, noted, “Wright has once again leveraged its proprietary BIOFOAM™ CANCELLOUS TITANIUM™ technology, this time as a bone in-growth coating for the DYNASTY® acetabular shell. Compared to traditional beaded surfaces, the BIOFOAM™ material has enhanced frictional properties to resist torque loads that could cause loosening. In addition, its reticulated structure and optimal porosity and pore size allow bone to penetrate deeply within the foam material, which enhances immediate fixation and longer-term bone ingrowth and implant stability.”

These facts have been demonstrated in a series of in-vivo pre-clinical studies performed at RUSH Presbyterian St. Luke’s University in Chicago, Illinois. This research demonstrated that Wright’s BIOFOAM™ implants had a 51% increase in shear strength at 12 weeks and a 253% increase in bone in-growth at 12 weeks when compared to sintered bead-coated implants.

The DYNASTY® BIOFOAM™ Acetabular Cup System represents the debut of Wright’s proprietary CANCELLOUS TITANIUM™ technology within its line of innovative hip products. The Company first introduced BIOFOAM™ CANCELLOUS TITANIUM™ fixation for its ADVANCE® Knee Systems in 2008.

Wright Medical Group, Inc. is a global orthopaedic medical device company specializing in the design, manufacture and marketing of reconstructive joint devices and biologics. The Company has been in business for more than 50 years and markets its products in over 60 countries worldwide. For more information about Wright Medical, visit the company’s website at


This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements made in this press release, other than statements of historical fact, are forward-looking statements. Forward-looking statements reflect management's current knowledge, assumptions, beliefs, estimates, and expectations and express management's current views of future performance, results, and trends and may be identified by their use of terms such as “anticipate,” “believe,” “could,” “estimate,” “expect,” “intend,” “may,” “plan,” “predict,” “project,” “will,” and other similar terms. The Company wishes to caution readers that actual results might differ materially from those described in the forward-looking statements. Forward-looking statements are subject to a number of risks and uncertainties, including the factors discussed in the Company’s filings with the Securities and Exchange Commission (including the Company’s annual report on Form 10-K for the year ended December 31, 2008, under the heading, “Risk Factors”), which could cause the Company’s actual results to materially differ from those described in the forward-looking statements. Although the Company believes that the forward-looking statements are accurate, there can be no assurance that any forward-looking statement will prove to be accurate. A forward-looking statement should not be regarded as a representation by the Company that the results described therein will be achieved. The Company wishes to caution readers not to place undue reliance on any forward-looking statement. The forward-looking statements are made as of the date of this press release. The Company assumes no obligation to update any forward-looking statement after this date.



Source: Wright Medical Group, Inc.

Wright Medical Group, Inc.
John K. Bakewell, 901-867-4527